Attention: your browser does not have JavaScript enabled!

For full functionality of this site it is necessary to enable JavaScript.
Click Here to learn how to enable JavaScript.

decision point logo
  • Home
  • About Us
  • Subscriptions
  • Blogs and Links
New around here? Subscribe now! Forgot password?

Manage Account

  • HOME
  • ABOUT US
  • SUBSCRIPTIONS
  • BLOGS AND LINKS

PMO BUY Signals Trigger on Technology and Healthcare Sectors

Published on February 08, 2022 at 07:51 PM by Erin Swenlin

DecisionPoint Alert

We had two sectors trigger new Price Momentum Oscillator (PMO) BUY signals today, Technology (XLK) and Healthcare (XLV). Let's look "under the hood" to see whether these PMO BUY signals mean more upside for both sectors. On the DecisionPoint.com website, subscribers have access to our "under the hood" sector charts that Carl keeps freshly annotated. They spotlight "participation" using %Stocks > 20/50/200-day EMAs and the Silver Cross Index (SCI)/Golden Cross Index (GCI).

Technology is actually pulling back a bit after failing to overcome resistance at the 50-day EMA. Despite a strong rally today, price closed below the 20-day EMA. The PMO may've triggered a crossover BUY signal, but the RSI is still in negative territory suggesting price weakness. There are pluses in addition to the PMO BUY signal. Participation of %Stocks > 20/50/200-EMAs is rising. %Stocks > 20/50-EMAs are higher than the Silver Cross Index (SCI) reading. This tells us that the SCI should continue to move higher since it measures %Stocks with a 20-EMA > 50-EMA. The Golden Cross Index (GCI) is still in decline and the %Stocks > 200-EMA is less than the GCI. This tells us that the long-term bias and foundation are bearish. Be careful with your positions in this sector.






Click here to register in advance for the recurring free DecisionPoint Trading Room! The most recent recording is below:

Topic: DecisionPoint Trading Room

Start Time: Feb 7, 2022 09:01 AM

Meeting Recording Link.

Access Passcode: February#7


XLV is consolidating sideways instead of in a declining trend like XLK. The RSI on XLV is positive as it rises above net neutral (50). The SCI is about to cross over its signal line. %Stocks > 20/50-EMAs are both well-above the SCI reading suggesting a bullish short-term bias. %Stocks > 200-day EMA is rising, but is not greater than the GCI which continues lower suggesting like XLK, there is still long-term weakness. Stochastics are rising and are above 80 which is bullish. When we compare these two sectors, XLV appears to have the stronger chart with "under the hood" indicators showing higher participation within that sector.

Conclusion: While both of these sectors are showing a strong shift in upside momentum, there are still problems, particularly in the long term. Price needs to trade completely above key moving averages on both of these sectors before we can trust them.

Best,

Erin Swenlin, VP & Senior Technical Analyst DecisionPoint.com


Technical Analysis is a windsock, not a crystal ball. --Carl Swenlin

(c) Copyright 2022 DecisionPoint.com


Helpful DecisionPoint Links:

DecisionPoint Alert Chart List

DecisionPoint Golden Cross/Silver Cross Index Chart List

DecisionPoint Sector Chart List

DecisionPoint Chart Gallery

Trend Models

Price Momentum Oscillator (PMO)

On Balance Volume

Swenlin Trading Oscillators (STO-B and STO-V)

ITBM and ITVM

SCTR Ranking


DecisionPoint is not a registered investment advisor. Investment and trading decisions are solely your responsibility. DecisionPoint newsletters, blogs or website materials should NOT be interpreted as a recommendation or solicitation to buy or sell any security or to take any specific action.

Blog Archive
Previous Article
Next Article

Contact Us

Email: support@decisionpoint.com

© Proudly created by Alamo City Marketing Solutions

Socialize With Us

DecisionPoint logo

DecisionPoint is not a registered investment advisor. Investment and trading decisions are solely your responsibility. None of the DecisionPoint newsletters or web site materials should be interpreted as a recommendation or solicitation to buy or sell any security or to take any specific action.

DecisionPoint does not represent or endorse the accuracy or reliability of any of the information, content, or advertisements contained on, distributed through, linked from, downloaded or otherwise accessed from any of the services contained on this web site or in our newsletters, nor the quality of any products, information or other materials displayed, purchased, or obtained by you as a result of an advertisement or any other information or offer in or in connection with the materials. You hereby acknowledge that any reliance upon any Materials shall be at your sole risk. It is your responsibility to verify from other sources, such as your broker, critical elements of a decision to act. DecisionPoint reserves the right, in its sole discretion and without any obligation, to make improvements/changes to, or to correct any error or omissions in any portion of the Materials.

THE SERVICE AND THE MATERIALS ARE PROVIDED BY DECISIONPOINT ON AN "AS IS" BASIS, AND DECISIONPOINT EXPRESSLY DISCLAIMS ANY AND ALL WARRANTIES, EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE, WITH RESPECT TO THE SERVICE OR ANY MATERIALS AND PRODUCTS. IN NO EVENT SHALL DECISIONPOINT BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, PUNITIVE, OR CONSEQUENTIAL DAMAGES OF ANY KIND WHATSOEVER WITH RESPECT TO THE SERVICE, THE MATERIALS AND THE PRODUCTS.